Stuart Atkinson

1.4k citations

40 papers · 983 indexed · h-index 15

Impact in

Gastroenterology top 0.5%
- Gastroesophageal reflux and treatments
- Gastrointestinal motility and disorders
Surgery top 5%
- Helicobacter pylori-related gastroenterology studies
- Eosinophilic Esophagitis
- Esophageal and GI Pathology

Papers in

Gastroenterology 22
- Gastroesophageal reflux and treatments 20
- Gastrointestinal motility and disorders 5
Endocrinology, Diabetes and Metabolism 9
- Hormonal and reproductive studies 9

Co-authors: Marsha G. Raanan Eric Hassall Susan R. Orenstein Wanda Furmaga-Jabłońska María Claudia Pérez Darcy J. Mulford David A. Peura Jingtao Wu
Journals: Alimentary Pharmacology & Therapeutics (10 papers)Journal of Clinical Oncology (6 papers)Digestive Diseases and Sciences (3 papers)International Journal of Clinical Practice (3 papers)Pediatric Drugs (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Stuart Atkinson

39 papers receiving 943 citations

Peers

Countries citing papers authored by Stuart Atkinson

Since Specialization

Citations

This map shows the geographic impact of Stuart Atkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Atkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Atkinson more than expected).

Fields of papers citing papers by Stuart Atkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Atkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Atkinson. The network helps show where Stuart Atkinson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stuart Atkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart Atkinson Line = papers co-authored together Stuart Atkinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	6-month Formulations of Androgen Deprivation Therapy for Advanced Prostate Cancer: Effectiveness and Rationale for Extended Dosing Jason Hafron, Stuart Atkinson, Gunnar Lien, Joseph Renzulli	2024	0
2	Patient Demographics and Major Adverse Cardiovascular Events after Androgen Deprivation Therapy for Prostate Cancer Advances in Urology ·Christopher J.D. Wallis, Kevin C. Chen, Stuart Atkinson, 加津代田中	2024	1
3	The effect of time‐of‐day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR: evidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor Alimentary Pharmacology & Therapeutics ·Shakhnoza Ametova, Darcy J. Mulford, Jingtao Wu, Stuart Atkinson	2010	33
4	Changes of gastric histology in patients with erosive oesophagitis receiving long‐term lansoprazole maintenance therapy Alimentary Pharmacology & Therapeutics ·Marian M. Haber, Barbara Hunt, James W. Freston, David A. Peura, T. O. G. Kovacs, Stuart Atkinson, Michie Hisada	2010	10
5	The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics ·Hans-Georg Werner, Cong Han, Maria Paris, María Claudia Pérez, Stuart Atkinson, David A. Peura	2010	7
6	Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole Digestive Diseases and Sciences ·Thomas O. Kovacs, James W. Freston, Marian M. Haber, Stuart Atkinson, Barbara Hunt, David A. Peura	2009	6
7	The clinical safety of long‐term lansoprazole for the maintenance of healed erosive oesophagitis Alimentary Pharmacology & Therapeutics ·James W. Freston, Michie Hisada, David A. Peura, Marian M. Haber, T. O. G. Kovacs, Stuart Atkinson, Barbara Hunt	2009	14
8	Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed‐release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis Alimentary Pharmacology & Therapeutics ·David C. Metz, Colin W. Howden, María Claudia Pérez, Lois Larsen, Janet O’Neil, Stuart Atkinson	2009	57
9	Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis – maintenance of healing and symptom relief Alimentary Pharmacology & Therapeutics ·Colin W. Howden, Lois Larsen, María Claudia Pérez, Robert Palmér, Stuart Atkinson	2009	34
10	Lack of Electrocardiographic Effect of Dexlansoprazole MR, a Novel Modified‐Release Formulation of the Proton Pump Inhibitor Dexlansoprazole, in Healthy Participants The Journal of Clinical Pharmacology ·Majid Vakily, Jingtao Wu, Stuart Atkinson	2009	6
11	Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor – evidence for dosing flexibility Alimentary Pharmacology & Therapeutics ·Shakhnoza Ametova, Majid Vakily, Darcy J. Mulford, Jingtao Wu, Stuart Atkinson	2009	45
12	Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials Current Medical Research and Opinion ·Majid Vakily, Weijiang Zhang, Jingtao Wu, Stuart Atkinson, Darcy J. Mulford	2009	81
13	Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects The Journal of Clinical Pharmacology ·Weijiang Zhang, Jingtao Wu, Stuart Atkinson	2009	13
14	Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis Digestive Diseases and Sciences ·Thomas O. Kovacs, James W. Freston, Marian M. Haber, Barbara Hunt, Stuart Atkinson, David A. Peura	2009	8
15	Lansoprazole for Long-Term Maintenance Therapy of Erosive Esophagitis: Double-Blind Comparison with Ranitidine Digestive Diseases and Sciences ·David A. Peura, James W. Freston, Marian M. Haber, Thomas O. Kovacs, Barbara Hunt, Stuart Atkinson	2008	5
16	Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Assessing the Efficacy and Safety of Proton Pump Inhibitor Lansoprazole in Infants with Symptoms of Gastroesophageal Reflux Disease The Journal of Pediatrics ·Susan R. Orenstein, Eric Hassall, Wanda Furmaga-Jabłońska, Stuart Atkinson, Marsha G. Raanan	2008	241
17	Greater Immediate Gastric Acid Suppression with Lansoprazole 30 mg Administered as a 2‐Minute Intravenous Bolus Injection versus a 30‐Minute Infusion Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·David C. Metz, John W. Devlin, Majid Vakily, Stuart Atkinson, Mariaelena Huambachano	2008	3
18	Safety and Pharmacodynamics of Lansoprazole in Patients with Gastroesophageal Reflux Disease Aged <1 Year Pediatric Drugs ·Noel Octaviano, Stuart Atkinson, 김효영, Marsha G. Raanan	2008	23
19	A comparison of mebeverine with high‐fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study International Journal of Clinical Practice ·Nicola Chapman, MC Easter, Ramendra Nath Mazumder, Stuart Atkinson	1990	13
20	A randomised, double‐blind study of mebeverine versus dicyclomine in the treatment of functional abdominal pain in young adults International Journal of Clinical Practice ·MC Easter, ARIANE DA SILVA BASTOS GELER, Stuart Atkinson, P. Prescott	1990	3

About Stuart Atkinson

Stuart Atkinson is a scholar working on Gastroenterology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Surgery and Geriatrics and Gerontology, having authored 40 papers that have together received 983 indexed citations. Recurring topics across this work include Gastroesophageal reflux and treatments (20 papers), Helicobacter pylori-related gastroenterology studies (20 papers), Eosinophilic Esophagitis (13 papers), Prostate Cancer Treatment and Research (11 papers), Hormonal and reproductive studies (9 papers), Gastrointestinal motility and disorders (5 papers), Sexual Differentiation and Disorders (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Gastroenterology (784 citations), Surgery (725 citations), Pharmacy (39 citations), Speech and Hearing (43 citations) and Pulmonary and Respiratory Medicine (206 citations). Stuart Atkinson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Marsha G. Raanan, Eric Hassall, Susan R. Orenstein, Wanda Furmaga-Jabłońska, María Claudia Pérez, Darcy J. Mulford, David A. Peura, Jingtao Wu, Majid Vakily and Weijiang Zhang. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Journal of Clinical Oncology, Digestive Diseases and Sciences, International Journal of Clinical Practice and Pediatric Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact